SCHEMBL19807189

SCHEMBL19807189

CCCCCCOc1ccc(-c2cnc(-c3ccc(C[C@H](NC(=O)c4ccc(C(C)(C)C)cc4)C(=O)NCC(O)O)cc3)nc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLG P00747 2/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ PPARG P37231 3/20 0.44
▸ KLKB1 P03952 1/20 0.44
▸ PPARA Q07869 1/20 0.44
▸ ITGB1 P05556 2/20 0.42
▸ ITGA4 P13612 2/20 0.42
▸ ITGB3 P05106 2/20 0.41
▸ ITGA2B P08514 2/20 0.41
▸ RARB P10826 3/20 0.40
▸ GCGR P47871 1/20 0.40
▸ CTSB P07858 1/20 0.40
▸ CTSS P25774 1/20 0.40
▸ CTSK P43235 1/20 0.40
▸ PRSS1 P07477 1/20 0.40
▸ PRSS2 P07478 1/20 0.40
▸ PRSS3 P35030 1/20 0.40
▸ EPHX2 P34913 1/20 0.39
▸ NR1H4 Q96RI1 1/20 0.39
▸ KIFC1 Q9BW19 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19807191 1.00 PLG (0.49) PLGL3MBTL1PPARGKLKB1PPARA
SCHEMBL16306101 0.93 PLG (0.48) PLGL3MBTL1PPARGKLKB1PPARA
SCHEMBL20900619 0.93 PLG (0.51) PLGL3MBTL1PPARGKLKB1PPARA
SCHEMBL15019646 0.91 PLG (0.49) PLGL3MBTL1PPARGKLKB1PPARA
SCHEMBL15019649 0.91 PLG (0.49) PLGL3MBTL1PPARGKLKB1PPARA
SCHEMBL15037417 0.91 PLG (0.49) PLGL3MBTL1PPARGKLKB1PPARA
SCHEMBL15037348 0.91 PLG (0.49) PLGL3MBTL1PPARGKLKB1PPARA
SCHEMBL16305825 0.90 GCGR (0.52) PLGL3MBTL1PPARGKLKB1PPARA
SCHEMBL16380079 0.90 GCGR (0.52) PLGL3MBTL1PPARGKLKB1PPARA
SCHEMBL15019651 0.90 GCGR (0.52) PLGL3MBTL1PPARGKLKB1PPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3008056-B1 NOVEL GLP-1 RECEPTOR MODULATORS CELGENE INT II SARL (CH) 2020-12-09 — — EP disclosed
US-20180021346-A1 NOVEL GLP-1 RECEPTOR MODULATORS RECEPTOS LLC 2018-01-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180021346-A1 NOVEL GLP-1 RECEPTOR MODULATORS GLP1R, GIPR, NPY1R PLG 3184/4885L3MBTL1 771/4885PPARG 317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback